SCHEMBL14108177

SCHEMBL14108177

CN(C(=O)CN)c1ccncc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ POLQ O75417 1/20 0.47
▸ CHRM5 P08912 1/20 0.45
▸ CHKA P35790 1/20 0.45
▸ MLYCD O95822 1/20 0.39
▸ MPO P05164 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ ADORA3 P0DMS8 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2A6 P11509 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ AOC3 Q16853 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ GABRP O00591 1/20 0.36
▸ GABRD O14764 1/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ GABRG2 P18507 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4705712 0.89 POLQ (0.49) KDM4EKMT2APOLQCHRM5CHKA
SCHEMBL13824325 0.83 POLQ (0.49) KDM4EKMT2APOLQCHRM5CHKA
SCHEMBL14192258 0.82 KMT2A (0.49) KDM4EKMT2APOLQCHRM5CHKA
SCHEMBL4294754 0.80 KMT2A (0.54) KDM4EKMT2APOLQCYP3A4CYP2C19
SCHEMBL24435364 0.79 KDM4E (0.46) KDM4EKMT2APOLQCHRM5CHKA
SCHEMBL4107217 0.78 ALDH1A1 (0.46) KDM4EKMT2AAOC3HTTGAA
SCHEMBL12763807 0.78 KDM4E (0.45) KDM4EKMT2APOLQCHRM5CHKA
SCHEMBL16353748 0.78 KDM4E (0.49) KDM4EKMT2APOLQCHRM5CHKA
SCHEMBL7502077 0.77 ALDH1A1 (0.41) KDM4EAOC3HTT
SCHEMBL7506948 0.77 POLQ (0.48) KDM4EPOLQAOC3GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7417152-B2 4-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B1 receptor antagonists for the treatment of inflammatory diseases ELAN PHARMACEUTICALS, INC. (US) 2008-08-26 — — US disclosed
Send feedback